Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2016-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2016.07.025PMID 27460699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.

  2016cited by this paper
• Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes

  2016cited by this paper
• Current Research Therapeutic Strategies for Alzheimer's Disease Treatment

  2016cited by this paper
• Current Approaches Against Alzheimer's Disease in Clinical Trials

  2016cited by this paper
• Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.

  2015cited by this paper
• Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents.

  2015cited by this paper
• Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.

  2015cited by this paper
• (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.

  2015cited by this paper
• Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity.

  2015cited by this paper
• Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease.

  2015cited by this paper
• New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.

  2015cited by this paper
• Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease.

  2015cited by this paper
• Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.

  2015cited by this paper
• Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.

  2015cited by this paper
• Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.

  2015cited by this paper
• Design, synthesis and anticholinesterase activity of novel benzylidenechroman-4-ones bearing cyclic amine side chain.

  2015cited by this paper
• Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

  2014cited by this paper
• New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.

  2014cited by this paper
• Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.

  2014cited by this paper
• Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.

  2014cited by this paper
• Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer's disease.

  2014cited by this paper
• Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.

  2014cited by this paper
• Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects.

  2014cited by this paper
• 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.

  2014cited by this paper
• Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin.

  2014cited by this paper
• Aza-BODIPY: improved synthesis and interaction with soluble Aβ1-42 oligomers.

  2013cited by this paper
• Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.

  2013cited by this paper
• Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.

  2013cited by this paper
• Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.

  2013cited by this paper
• Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.

  2013cited by this paper
• Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors.

  2013cited by this paper
• Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment.

  2012cited by this paper
• Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors.

  2012cited by this paper
• Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.

  2012cited by this paper
• Highly selective inhibition of butyrylcholinesterase by a novel melatonin–tacrine heterodimers

  2012cited by this paper
• Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.

  2012cited by this paper
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide.

  2012cited by this paper
• New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.

  2012cited by this paper
• Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases.

  2012cited by this paper
• Alzheimer's disease: a general introduction and pathomechanism.

  2010cited by this paper
• A New Tacrine–Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease

  2010cited by this paper
• Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex

  2010cited by this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cited by this paper
• Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation.

  2009cited by this paper
• Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties

  2009cited by this paper
• Oxidative Stress in Diabetes and Alzheimer's Disease

  2009cited by this paper
• Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.

  2008cited by this paper
• Alzheimer disease and the role of free radicals in the pathogenesis of the disease.

  2008cited by this paper
• Amyloid–cholinesterase interactions

  2008cited by this paper
• Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations

  2007cited by this paper
• Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models

  2004cited by this paper
• Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay.

  2004cited by this paper
• Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.

  2003cited by this paper
• Treatment of Alzheimer's disease: current status and new perspectives.

  2003cited by this paper
• High throughput artificial membrane permeability assay for blood-brain barrier.

  2003cited by this paper
• Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease.

  2002cited by this paper
• Melatonin and Biological Rhythms

  1998cited by this paper
• [Melatonin and biological rhythms].

  1998cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Structural Engineering of Tyrosine-Based Neuroprotective Peptides: A New Strategy for Efficient Blood–Brain Barrier Penetration

  2025influential citation
• Computational Design and Assessment of Bi‐Heterocyclic Donepezil Derivatives as Enhanced Acetylcholinesterase Inhibitors

  2025cites this paper
• Antioxidants in Anti-Alzheimer's Disease Drug Discovery.

  2025cites this paper
• NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE

  2025cites this paper
• Review on anti-alzheimer drug development: approaches, challenges and perspectives

  2024cites this paper
• N‐Benzyl piperidine Fragment in Drug Discovery

  2024cites this paper
• Protective Activity of Melatonin Combinations and Melatonin‐Based Hybrid Molecules in Neurodegenerative Diseases

  2024cites this paper
• Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System.

  2024cites this paper
• Some Heterocycles Connected to Substituted Piperazine by 1,3,4-Oxadiazole Linker: Design, Synthesis, Anticholinesterase and Antioxidant Activity

  2024cites this paper
• Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer’s Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention

  2023cites this paper
• Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease

  2023cites this paper
• Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors.

  2023cites this paper
• Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3‐Hydroxypyridine‐4‐one Derivatives as Potential Acetylcholinesterase Inhibitors

  2023cites this paper
• New indole derivatives as multitarget anti-Alzheimer's agents: synthesis, biological evaluation and molecular dynamics.

  2023cites this paper
• 2D QSAR STUDY OF FUSED 5,6-BICYCLIC HETEROCYCLES AS ANTI ALZHEIMER’S AGENTS USING TOPOLOGICAL PARAMETERS

  2023cites this paper
• Tryptamine: A privileged scaffold for the management of Alzheimer's disease

  2023cites this paper
• Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies

  2022cites this paper
• Structure-activity and binding orientations analysis of potent, newly synthesized, acetylcholinesterase inhibitors

  2022cites this paper
• Study on Multi-target Synergistic Treatment of Alzheimer's Disease Based on Metal Chelators.

  2022cites this paper
• Design synthesis and In vitro evaluation of Tacrine- Flavone hybrids as Multifunctional Cholinesterase inhibitors for Alzheimer's disease.

  2022cites this paper
• Natural Chimeras of Existing Drugs for Alzheimer’s Disease: Expanding the Target Landscape

  2021influential citation
• Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy

  2021cites this paper
• The hybrid compounds as multi-target ligands for the treatment of Alzheimer's Disease: Considerations on Donepezil.

  2021cites this paper
• The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

  2021cites this paper
• Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.

  2021cites this paper
• Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors.

  2021cites this paper
• Donepezil: A review of the recent structural modifications and their impact on anti-Alzheimer activity

  2020cites this paper
• Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on

  2020cites this paper
• Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease

  2020cites this paper
• Lipase-catalysed synthesis of a novel galanthamine derivative: Process optimization by artificial neural networks

  2020cites this paper
• Synthesis of furocoumarin-stilbene hybrids as potential multifunctional drugs against multiple biochemical targets associated with Alzheimer's disease.

  2020cites this paper
• Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

  2020cites this paper
• Free radical scavengers: An overview on heterocyclic advances and medicinal prospects.

  2020cites this paper
• From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease

  2020cites this paper
• Design, synthesis and biological activity evaluation of novel carbazole-benzylpiperidine hybrids as potential anti Alzheimer agents

  2020cites this paper
• Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor.

  2020cites this paper
• Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening.

  2020cites this paper
• Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.

  2019cites this paper
• Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds.

  2019cites this paper
• Indole-based melatonin analogues: Synthetic approaches and biological activity.

  2019cites this paper
• Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies

  2019cites this paper
• Curcumin, Hormesis and the Nervous System

  2019cites this paper
• Inhibitory Effects of Novel 7-Substituted 6-iodo-3-O-Flavonol Glycosides against Cholinesterases and β-secretase Activities, and Evaluation for Potential Antioxidant Properties

  2019cites this paper
• Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues.

  2018cites this paper
• Synthesis and Evaluation of the 4-Substituted 2-Hydroxy-5-Iodochalcones and Their 7-Substituted 6-Iodoflavonol Derivatives for Inhibitory Effect on Cholinesterases and β-Secretase

  2018cites this paper
• Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders

  2018cites this paper
• Donepezil–melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments

  2018cites this paper
• Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.

  2018cites this paper
• Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation

  2018cites this paper
• Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders.

  2018cites this paper
• Multifunctional cholinesterase inhibitors for Alzheimer's disease: Synthesis, biological evaluations, and docking studies of o/p‐propoxyphenylsubstituted‐1H‐benzimidazole derivatives

  2018cites this paper
• Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.

  2018cites this paper
• Melatonin receptors: molecular pharmacology and signalling in the context of system bias

  2018cites this paper
• Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues

  2018cites this paper
• Endogenous non-enzymatic antioxidants in the human body.

  2018cites this paper
• New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.

  2018cites this paper
• Profiling donepezil template into multipotent hybrids with antioxidant properties

  2018cites this paper
• Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors.

  2018cites this paper
• Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease

  2018cites this paper
• Melatonin ameliorates Aβ1‐42‐induced Alzheimer's cognitive deficits in mouse model

  2018cites this paper
• Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.

  2018cites this paper
• The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease

  2017cites this paper
• Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.

  2017cites this paper
• Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.

  2017cites this paper
• Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.

  2017cites this paper
• Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors.

  2017cites this paper
• Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.

  2017cites this paper
• The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.

  2016cites this paper